A Recombinant, Chimeric Enzyme With a Novel Mechanism of Action Leading to Greater Potency and Selectivity Than Tissue-Type Plasminogen Activator

Circulation - United States
doi 10.1161/01.cir.86.2.548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Successful Thrombolytic Therapy With Recombinant Tissue-Type Plasminogen Activator for Massive Pulmonary Embolism -A Case Report-

Korean Journal of Anesthesiology
AnesthesiologyPain Medicine
2010English

Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

BUNP: A Novel Designer pGC-A/cGMP Activator With Enhanced Potency and High Selectivity in Vitro

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Expanding Recombinant Tissue Plasminogen Activator Time Window Is Premature

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).

The Japanese Journal of Pharmacology
1994English

Tissue-Type Plasminogen Activator: A Role for O-Linked Fucose.

Journal of Clinical Investigation
Medicine
1994English

Intracisternal Recombinant Tissue Plasminogen Activator After Aneurysmal Subarachnoid Hemorrhage

Journal of Neurosurgery
SurgeryNeurology
1991English

Mechanism of Action and Selectivity of a Novel Fungicide, Pyribencarb

Journal of Pesticide Sciences
MutagenesisHealthInsect ScienceToxicology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy